Regeneron Pharmaceuticals Unusual Options Activity

A whale with a lot of money to spend has taken a noticeably bearish stance on Regeneron Pharmaceuticals.

Looking at options history for Regeneron Pharmaceuticals REGN we detected 10 strange trades.

If we consider the specifics of each trade, it is accurate to state that 20% of the investors opened trades with bullish expectations and 80% with bearish.

From the overall spotted trades, 6 are puts, for a total amount of $346,389 and 4, calls, for a total amount of $261,957.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $770.0 to $835.0 for Regeneron Pharmaceuticals over the last 3 months.

Volume & Open Interest Development

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Regeneron Pharmaceuticals's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Regeneron Pharmaceuticals's whale trades within a strike price range from $770.0 to $835.0 in the last 30 days.

Regeneron Pharmaceuticals Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
REGN PUT SWEEP BULLISH 02/16/24 $805.00 $143.0K 0 0
REGN CALL TRADE NEUTRAL 01/17/25 $780.00 $108.4K 121 8
REGN CALL SWEEP BULLISH 11/03/23 $790.00 $67.9K 52 82
REGN PUT TRADE BEARISH 06/21/24 $780.00 $55.7K 247 10
REGN PUT SWEEP BEARISH 11/03/23 $770.00 $50.6K 10 88

Ready to win big? Discover the #1 strategy for trading options in today's unpredictable market... with potential gains of 44%, 125% and even 411% every month on average. Starting at only $1 a day. Click here now.

Where Is Regeneron Pharmaceuticals Standing Right Now?

  • With a volume of 238,519, the price of REGN is up 1.52% at $791.76.
  • RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
  • Next earnings are expected to be released in 1 days.

What The Experts Say On Regeneron Pharmaceuticals:

  • Morgan Stanley has decided to maintain their Overweight rating on Regeneron Pharmaceuticals, which currently sits at a price target of $915.
  • Cantor Fitzgerald has decided to maintain their Neutral rating on Regeneron Pharmaceuticals, which currently sits at a price target of $850.
  • RBC Capital has decided to maintain their Sector Perform rating on Regeneron Pharmaceuticals, which currently sits at a price target of $847.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Regeneron Pharmaceuticals, Benzinga Pro gives you real-time options trades alerts.

Market News and Data brought to you by Benzinga APIs
Date of Trade
▲▼
ticker
▲▼
Put/Call
▲▼
Strike Price
▲▼
DTE
▲▼
Sentiment
▲▼
Posted In: OptionsMarketsBZI-UOA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...